86 results
Page 2 of 5
F-3
cg9hotf13s 22qy6
17 Feb 22
Shelf registration (foreign)
4:14pm
F-3
qrmw86r9op0 bo54uw
17 Feb 22
Shelf registration (foreign)
4:14pm
F-3
EX-5.1
fzk2uiqg
17 Feb 22
Shelf registration (foreign)
4:14pm
6-K
EX-99.3
brza z2iv
28 Jan 22
ObsEva Announces Corporate Updates
5:16pm
424B7
ukj66qyn as6w53r5po
23 Nov 21
Prospectus with selling stockholder info
4:06pm
F-3
ysufg9zp91cunu mx
10 Nov 21
Shelf registration (foreign)
5:23pm
F-3
EX-5.1
2y2did
10 Nov 21
Shelf registration (foreign)
5:23pm
6-K/A
EX-99.2
goij byzv0me77n
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K/A
EX-99.5
f76sx2b6md1 rq9w
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K/A
EX-99.1
d4rufhieac6oxr
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K
EX-99.5
se28sowv fkno
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.1
b79eqsp
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.2
5iy9ltuto
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.1
bq6e4trwx9 ax4
22 Apr 21
ObsEva Annual General Meeting 2021
6:31am
6-K
EX-5.1
w4udkujvw3wph
5 Mar 21
Current report (foreign)
8:15am
6-K
EX-1.1
n1llsdaem7h22v5410
5 Mar 21
Current report (foreign)
8:15am
424B5
aiz2gc0ysl0mas8y6nw
5 Mar 21
Prospectus supplement for primary offering
7:55am